Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4761 - 4768 of 11616 results
CMS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads
May 9, 2019| Blog| Viewpoint
ML Strategies Health Care Preview: House Poised to Pass First Drug Pricing Bills
May 8, 2019| Blog| Viewpoint
Drones and Sports? Pro Leagues and NCAA Weigh In
May 7, 2019| Blog| Viewpoint
Where Both Parties Behave Badly in Litigation, Attorneys’ Fees Are Unlikely to Be Awarded
May 7, 2019| Blog| Viewpoint
FCA Challenge Poses 2 Potential Questions For Justices
May 6, 2019| News
The Big Mistake Too Many Retirement Plan Fiduciary Committees are Making—And What to Do About It
May 3, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.